| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 0mg | ¥ ƤIJŻǟǑǑ | > | > | 1 | 1 | 1 | 1 | ¥ ƤIJŻǟǑǑ | - + |
| 20mg | ¥ DžǪǑǟǑǑ | > | > | 2 | 1 | 2 | 1 | ¥ DžǪǑǟǑǑ | - + |
| 1g | ¥ ŻƹIJǟǑǑ | > | 6 | 2 | 2 | 2 | 2 | ¥ ŻƹIJǟǑǑ | - + |
| g | ¥ IJǪǷǑǟǑǑ | > | 1 | -- | 1 | 1 | -- | ¥ IJǪǷǑǟǑǑ | - + |
| g | ¥ DžƤŻȏǟǑǑ | > | -- | -- | -- | -- | -- | ¥ DžƤŻȏǟǑǑ | - + |
| 2g | ¥ ŻƹDžƈǟǑǑ | 6 | -- | -- | -- | -- | -- | ¥ ŻƹDžƈǟǑǑ | - + |
| 0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
230.32
[1]. Dorywalska M, et al. Effect of attachment site on stability of cleavable antibody drug conjugates. Bioconjug Chem. 201 Apr 1;26(4):60-9.
[2]. Dubowchik GM, et al. Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity. Bioconjug Chem. 2002 Jul-Aug;13(4):8-69.
[3]. Yoneda Y, et al. A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy. Bioorg Med Chem Lett. 2008 Mar 1;18():32-6.
H302-H31-H319-H33
P261-P264-P270-P271-P280-P302+P32-P304+P340-P30+P31+P338-P330-P362+P364-P403+P233-P40-P01
![]()